Table 1.
Clinical characteristic and biochemical data of the study subjects
| Control (n = 31) | PCOS (n = 31) | p value | |
|---|---|---|---|
| Age [years] | 24.52 ± 2.31 | 24.20 ± 4.49 | 0.750 |
| BMI [kg/m2] | 20.48 ± 2.67 | 22.27 ± 3.56 | 0.081 |
| Fasting glucose [mmol/L] | 4.68 ± 0.42 | 5.25 ± 1.20 | 0.026 < 0.05 |
| Fasting insulin [pmol/L] | 6.9 ± 3.38 | 14.10 ± 13.83 | 0.007 < 0.05 |
| FSH [IU/L] | 5.15 ± 1.32 | 5.59 ± 2.86 | 0.440 |
| LH [IU/L] | 5.85 ± 2.74 | 9.82 ± 8.57 | 0.017 < 0.05 |
| LH/FSH | 1.14 ± 0.50 | 1.73 ± 0.97 | 0.003 < 0.01 |
| PRL [mIU/L] | 466.83 ± 231.05 | 309.64 ± 158.59 | 0.003 < 0.01 |
| E2 [pmol/L] | 209.95 ± 127.20 | 220.25 ± 246.80 | 0.837 |
| T [nmol/L] | 1.12 ± 0.40 | 1.65 ± 0.67 | < 0.001 |
| P [nmol/L] | 0.93 ± 0.36 | 1.05 ± 0.80 | 0.451 |
| TC [mmol/L] | 4.44 ± 0.63 | 4.65 ± 0.76 | 0.306 |
| TG [mmol/L] | 0.75 ± 0.29 | 1.13 ± 0.51 | 0.002 < 0.05 |
| HDL-c [mmol/L] | 2.23 ± 0.52 | 1.46 ± 0.41 | < 0.001 |
| LDL-c [mmol/L] | 1.69 ± 0.29 | 2.54 ± 0.62 | < 0.001 |
BMI body mass index, FSH follicle-stimulating hormone, LH luteinizing hormone, PRL prolactin, E2 estradiol, T testosterone, P progesterone, TC total cholesterol, TG triglyceride, HDL-c high-density lipoprotein cholesterol, LDL-c low-density lipoprotein cholesterol